Clinical outcomes of metabolomics and gut microbiota in the treatment of inflammatory bowel diseases: a systematic review
Introduction: Inflammatory bowel diseases (IBDs) are multifactorial diseases characterized by chronic inflammation of the gastrointestinal tract. Nutrients, gut microbiota, exosomes, and microRNAs play crucial roles in the pathophysiology of IBD. Objective: It was to conduct a systematic review of the main clinical stu...